ÂÜÀòÂÒÂ×

Harvir Grewal is a CMC Upstream Scientist with experience in upstream process development for rAAV gene therapy at Kate Therapeutics and Voyager Therapeutics, Inc. Previously, Harvir worked at Pfizer as a Cell Culture Process Development Co-op and at Northeastern University and Truman State University in various research and assistant roles. Harvir holds a Master of Science in Bioengineering and Biomedical Engineering from Northeastern University and a Bachelor of Science in Biology from Truman State University.